These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17578316)

  • 41. Clinical study on safety of cantharidin sodium and shenmai injection combined with chemotherapy in treating patients with breast cancer postoperatively.
    Wang L; Huang XE; Cao J
    Asian Pac J Cancer Prev; 2014; 15(14):5597-600. PubMed ID: 25081671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Randomized controlled clinical trial of kang'ai injection in gastrointestinal cancerchemotherapy patients].
    Chen Y; Zhong MZ; Lu M
    Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(19):2990-2. PubMed ID: 23270248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparative study of chemosensitivity and efficacy between pirarubicin and epirubicin in breast cancer].
    Zang MF; Zhang YM; Zhi YH; Zhai Z; Zhang M; Gu F; Zhi XC
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1388-92. PubMed ID: 21756809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Fuzheng Yiliu decoction combined with chemotherapy on patients with intermediate and late stage gastrointestinal cancer.
    Pan B; Cheng T; Nan KJ; Qiu GQ; Sun XC
    World J Gastroenterol; 2005 Jan; 11(3):439-42. PubMed ID: 15637764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Muehrcke's lines on nails after cyclophosphamide/adriamycin/fluorouracil.
    Gül U; Kiliç A
    Ann Pharmacother; 2004 Jun; 38(6):1089-90. PubMed ID: 15122002
    [No Abstract]   [Full Text] [Related]  

  • 46. Association of angiogenesis and disease outcome in node-positive breast cancer patients treated with adjuvant cyclophosphamide, doxorubicin, and fluorouracil: a Cancer and Leukemia Group B correlative science study from protocols 8541/8869.
    Guidi AJ; Berry DA; Broadwater G; Helmchen B; Bleiweiss IJ; Budman DR; Henderson IC; Norton L; Hayes DF
    J Clin Oncol; 2002 Feb; 20(3):732-42. PubMed ID: 11821455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benefit of the addition of paclitaxel to standard chemotherapy with 5-fluorouracil/doxorubicin/cyclophosphamide in patients with operable breast cancer.
    Clin Breast Cancer; 2000 Oct; 1(3):189-90. PubMed ID: 11899642
    [No Abstract]   [Full Text] [Related]  

  • 48. [Immune enhancing effect of modified sijunzi decoction on patients with colorectal cancer undergoing chemotherapy].
    Xiao H; Yang J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):164-7. PubMed ID: 21425566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged disease control after myeloablative chemotherapy, autologous transplantation and immunotherapy in high-risk early breast cancer.
    Recchia F; Candeloro G; Necozione S; Accorsi P; Recchia CO; Tombolini V; Rea S
    Anticancer Res; 2010 Jan; 30(1):209-15. PubMed ID: 20150637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of astragalus injection combined with chemotherapy on quality of life in patients with advanced non-small cell lung cancer].
    Zou YH; Liu XM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Oct; 23(10):733-5. PubMed ID: 14626183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of parenterally administered shenqi fuzheng on patient outcomes with tumor using propensity score].
    Ai QH; Zeng XB; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3129-36. PubMed ID: 24471340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antitumor effect of combination of cyclophosphamide, adriamycin and platinum (CAP) versus cyclophosphamide, adriamycin and 5-fluorouracil (CAF) in metastatic breast cancer.
    Tzekova V; Velikova M; Koynov K; Micheva D; Donchev T
    Neoplasma; 1991; 38(6):603-7. PubMed ID: 1766485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of pulmonary arterial perfusion with shenqi fuzheng injection on lung injury during cardiopulmonary bypass].
    Yi S; Ran L; Gu XH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Oct; 26(10):938-41. PubMed ID: 17121051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil).
    Hatam N; Ahmadloo N; Ahmad Kia Daliri A; Bastani P; Askarian M
    Arch Gynecol Obstet; 2011 Jul; 284(1):215-20. PubMed ID: 20740365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Studies of guben quyu No I combined with chemotherapy in treating cancer].
    Yu RC; Peng XM; Rao XQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Jul; 14(7):392-5. PubMed ID: 7950221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunoregulation and short-term therapeutic effects of super-selective intra-arterial chemotherapy combined with traditional Chinese drugs on gastric cancer patients].
    Zhu JS; Song MQ; Wang L; Sun Q; Zhu L; Fang C
    Zhong Xi Yi Jie He Xue Bao; 2006 Sep; 4(5):478-81. PubMed ID: 16965740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study.
    Fetting JH; Gray R; Fairclough DL; Smith TJ; Margolin KA; Citron ML; Grove-Conrad M; Cella D; Pandya K; Robert N; Henderson IC; Osborne CK; Abeloff MD
    J Clin Oncol; 1998 Jul; 16(7):2382-91. PubMed ID: 9667255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A meta-analysis of Shenqi Fuzheng combined with radiation in the treatment of nonsmall cell lung cancer.
    Jiang H; Zhang H; Hu X; Ma J
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C101-3. PubMed ID: 26323903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shenfu injection for improving cellular immunity and clinical outcome in patients with sepsis or septic shock.
    Zhang N; Liu J; Qiu Z; Ye Y; Zhang J; Lou T
    Am J Emerg Med; 2017 Jan; 35(1):1-6. PubMed ID: 28029485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.
    Parnes HL; Cirrincione C; Aisner J; Berry DA; Allen SL; Abrams J; Chuang E; Cooper MR; Perry MC; Duggan DB; Szatrowski TP; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1819-24. PubMed ID: 12721259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.